Roger New
Vorsitzender bei Proxima Concepts Ltd.
Profil
Roger New was the founder of Botanix Pharmaceuticals Ltd.
(founded in 1984) where he held the title of Non-Executive Chairman & Chief Scientific Officer from 2012 to 2014.
He was also the founder of Kancer Ltd.
(founded in 1980) where he served as a Co-Founding Director.
Currently, Dr. New is the Chairman & Chief Scientific Officer at Proxima Concepts Ltd.
since 2012.
He is also the Chief Scientist at Proxima Corp.
since 2000 and the Chief Scientific Officer at Diabetology Ltd.
In the past, Dr. New worked as a Director at Bone, Ltd.
and as a Principal at Provalis Plc.
Aktive Positionen von Roger New
| Unternehmen | Position | Beginn |
|---|---|---|
Diabetology Ltd.
 Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Technik-/Wissenschafts-/F&E-Leiter | - |
Proxima Corp.
 Proxima Corp. Computer PeripheralsElectronic Technology Part of Ask ASA, Proxima Corp. is a company that makes multimedia projection products. The company is based in Wilsonville, OR. Proxima was acquired by Ask ASA on April 13, 1998 for $82.03 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 |
| Proxima Concepts Ltd. | Vorsitzender | 27.03.2012 |
Ehemalige bekannte Positionen von Roger New
| Unternehmen | Position | Ende |
|---|---|---|
| Bone, Ltd. | Direktor/Vorstandsmitglied | 16.03.2011 |
Kancer Ltd.
 Kancer Ltd. Miscellaneous Commercial ServicesCommercial Services Kancer Ltd. engages in the provision of cancer treatments. Its projects include personalized medicine, targeted destruction of cancer cells, oral granulocyte colony stimulating factor , and oral interferon. The company was founded by Glen Travers and Roger New in 1980 and is headquartered in Saint Helier, the United Kingdom. | Gründer | - |
| BOTANIX PHARMACEUTICALS LIMITED | Gründer | - |
| Provalis Plc | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Diabetology Ltd.
Diabetology Ltd. Miscellaneous Commercial ServicesCommercial Services Diabetology Ltd. offers biopharmaceutical research and development services. It develops Capsulin and novel Axcess oral form of insulin for diabetics that incorporates absorption enhancers with unmodified bioactive in a convenient encapsulated form. The company was founded by Roger New and Glen Travers in 2002 and is headquartered in St. Helier, Jersey. | Commercial Services |
| Provalis Plc | Health Technology |
Proxima Corp.
Proxima Corp. Computer PeripheralsElectronic Technology Part of Ask ASA, Proxima Corp. is a company that makes multimedia projection products. The company is based in Wilsonville, OR. Proxima was acquired by Ask ASA on April 13, 1998 for $82.03 million. | Electronic Technology |
| Bone, Ltd. | Health Technology |
| Proxima Concepts Ltd. | |
Kancer Ltd.
Kancer Ltd. Miscellaneous Commercial ServicesCommercial Services Kancer Ltd. engages in the provision of cancer treatments. Its projects include personalized medicine, targeted destruction of cancer cells, oral granulocyte colony stimulating factor , and oral interferon. The company was founded by Glen Travers and Roger New in 1980 and is headquartered in Saint Helier, the United Kingdom. | Commercial Services |
